![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Clinical Trials
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior...
News
CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report
The global contact services sector is benefiting from a switch towards COVID-19 manufacturing (vaccine and therapy) and clinical stage contracts, but mega-cap innovator drug...
Press Releases
AmerisourceBergen Reaches agreement with US CDC to support independent retail pharmacies access to COVID-19 vaccine
AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network...
Clinical Trials
Phesi analysis shows difference of up to three months in current COVID-19 vaccine trial recruitment
Analysis from virtual clinical development specialist Phesi shows the enrollment and effectiveness of two current COVID-19 vaccine trials conducted by global pharmaceutical development companies....
Clinical Trials
Tiziana begins study of nasally administered Foralumab either alone or in combo with dexamethasone to treat COVID-19 in Brazil
Tiziana Life Sciences, a biotechnology company, announced initiation of a collaborative clinical study investigating nasally administered Foralumab either alone or in combination with orally...
News
Novavax expands in Maryland as it gears up for late-stage COVID vaccine trial in the U.S.
Novavax has spent much of 2020 advancing its COVID-19 vaccine candidate through early-stage testing and preparing for manufacturing and distribution. And thanks to the...
News
Mumbai’s Sion Hospital to start phase-3 trials of first indigenous Covid vaccine
The Lokmanya Tilak General Hospital, also known as Sion Hospital, will soon start phase-3 clinical trials of India’s indigenous Covid-19 vaccine—COVAXINTM. As many as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read